Lenalidomide Price Comparison (India vs USA 2026): Cost, Generics, Safety & Savings Guide

SEO Meta & Title

Page Title

Meta Description

Compare Lenalidomide price in India vs US. Explore Revlimid costs, India generic savings, trusted suppliers, and 2026 procurement guidance.

Hero Section (Above-the-Fold)

H1 Title

Lenalidomide Price Comparison (India vs US): Complete 2026 Buyer Guide

Hero Subtitle

Discover how Lenalidomide pricing differs between India and the US for multiple myeloma treatment. Compare branded Revlimid, India generics, clinical value, and procurement advantages for patients and buyers.

CTA Buttons

Request Latest Quote

Talk to Supply Expert

Drug Overview

Lenalidomide is one of the most important oral therapies used in hematology oncology, especially for multiple myeloma and myelodysplastic syndromes. When evaluating Lenalidomide price comparison (India vs US), patients and procurement professionals often discover dramatic cost differences that directly affect long-term treatment access.

Originally developed by Celgene and later acquired by Bristol Myers Squibb, Lenalidomide is marketed globally under the brand name Revlimid. It received U.S. FDA approval for multiple myeloma and MDS and quickly became a standard therapy because of strong survival benefits and effective maintenance treatment outcomes.

Lenalidomide belongs to the immunomodulatory drug (IMiD) class. It works by enhancing immune system response, reducing abnormal blood vessel growth that supports tumor progression, and directly suppressing malignant plasma cells. This multi-pathway mechanism makes it highly effective in combination with dexamethasone, bortezomib, and monoclonal antibody regimens.

Its major approved indications include multiple myeloma, myelodysplastic syndrome with deletion 5q, mantle cell lymphoma, follicular lymphoma, and marginal zone lymphoma. In multiple myeloma, it is commonly used for induction therapy, post-transplant maintenance, and relapse management.

Clinical studies such as the FIRST trial and maintenance therapy trials showed significantly improved progression-free survival and overall survival when Lenalidomide was used as continuous treatment. This has made it a long-term therapy for many patients, which increases the importance of affordable pricing.

The biggest challenge remains cost. In the United States, branded Revlimid pricing can be extremely high, often creating major financial barriers. In contrast, India generic Lenalidomide from WHO-GMP and USFDA-compliant manufacturers offers substantial savings while maintaining therapeutic equivalence for eligible markets.

Global Brand Revlimid

Original Brand vs India Generic Comparison

Parameter	Original Brand (Revlimid)	India Generic Lenalidomide
Manufacturer	Bristol Myers Squibb	Natco / Cipla / Dr. Reddy’s / Hetero
Strengths	5mg / 10mg / 15mg / 25mg	Equivalent strengths available
Monthly Cost	Very High	70–90% Lower
Certification	USFDA / EMA	WHO-GMP / USFDA / EU GMP
Global Access	Limited by price	Broad international supply support

Lenalidomide Price Comparison (India vs US)

Why Choose India Generic

India has become a preferred sourcing destination for long-term oncology medicines like Lenalidomide because treatment affordability directly impacts patient outcomes and procurement continuity.

“Generic lenalidomide capsules India cost savings

Major Price Advantage: Generic Lenalidomide can reduce treatment cost by 70–90% compared to US branded Revlimid pricing.
WHO-GMP Certified Manufacturing: Facilities follow strict international quality standards for oncology production.
USFDA and EU GMP Compliance: Many Indian manufacturers serve highly regulated global export markets.
Large Production Capacity: Reliable manufacturing reduces risk of stock shortages for hospitals and distributors.
Strong API Supply Chain: Domestic pharmaceutical ecosystem improves stability and supply confidence.
9S Network Assurance: Verified sourcing, regulatory documentation, and export support improve procurement security.
Flexible MOQ Options: Suitable for both institutional and individual treatment planning.
Faster Global Delivery: India’s export infrastructure supports efficient lead times for urgent oncology needs.

According to WHO manufacturing data and 2026 oncology export reports, India continues to lead global supply for affordable hematology generics, making it a trusted option for both patient access and hospital procurement programs.

Member Manufacturers Directory

Company	Strengths Available	Monthly Capacity	MOQ	Certification	Action
Natco Pharma	5mg / 10mg / 15mg / 25mg	900K+ boxes	100 boxes	WHO-GMP, EU GMP	Request Quote
Cipla	Multiple strengths	1M+ boxes	100 boxes	WHO-GMP, USFDA	Request Quote
Hetero	Full oncology range	850K+ boxes	100 boxes	WHO-GMP, USFDA	Request Quote
Dr. Reddy’s	5mg–25mg	800K+ boxes	100 boxes	WHO-GMP, USFDA	Request Quote
Sun Pharma	Multiple strengths	950K+ boxes	100 boxes	WHO-GMP, USFDA	Request Quote

Price & Supply Information (2026 Q2 Latest Quotation)

Wholesale Price Range:

India Generic Lenalidomide: USD 49–99/30 tablet per box depending on strength and manufacturer
US Branded Revlimid: significantly higher, often several thousand USD monthly

Supply Status: Stable export availability with strong India manufacturing support.

Lead Time: Standard dispatch 7–15 working days depending on export documentation and destination country.

Download Latest Lenalidomide Quotation

Clinical Data & FAQ

Key Clinical Study Summary

The FIRST trial and multiple maintenance studies confirmed that continuous Lenalidomide treatment improves progression-free survival and overall survival in multiple myeloma patients, especially after stem cell transplant or in transplant-ineligible patients.

FAQ

1. Why is Lenalidomide so expensive in the US?
Branded Revlimid pricing includes original research costs, patent history, market exclusivity, and healthcare pricing structures. This makes treatment extremely expensive for long-term therapy, especially in multiple myeloma maintenance settings.

2. Is India generic Lenalidomide effective?
Yes. When sourced from WHO-GMP and USFDA-compliant manufacturers, generic Lenalidomide is widely used and considered therapeutically reliable in eligible markets. Verified sourcing is essential for quality assurance.

3. What is the biggest price difference between India and the US?
The cost difference can be dramatic. Many buyers see 70–90% savings with India generic Lenalidomide compared to branded Revlimid purchased in the United States.

4. What cancers are treated with Lenalidomide?
Lenalidomide is mainly used for multiple myeloma, myelodysplastic syndrome with deletion 5q, mantle cell lymphoma, follicular lymphoma, and marginal zone lymphoma.

5. Can hospitals import generic Lenalidomide from India?
Yes, depending on local regulations. Institutional buyers often work with verified suppliers like 9S Pharmacy Service for documentation, quotations, and export compliance support.

6. Is Lenalidomide used for maintenance therapy?
Yes. It is commonly prescribed after stem cell transplant and in long-term disease control strategies because it helps maintain remission and delay relapse.

7. Are there safety concerns with long-term use?
Yes. Common monitoring includes blood counts, clotting risk, infection prevention, and pregnancy precautions because Lenalidomide requires strict safety protocols.

8. How can international buyers get the latest quotation?
Buyers can contact 9S Pharmacy Service directly for updated pricing, verified manufacturer options, supply schedules, and procurement consultation.

Footer CTA & Trust Signals

Need verified Lenalidomide supply support?

Contact 9S Pharmacy Service Now

Trust Badges

WHO-GMP Certified Facilities
USFDA Approved Manufacturers
EDQM Compliance Support
Global Export Documentation
Verified Oncology Supplier Network

Contact: contact@984online.com